November 22, 2026
Uncategorized

Brokerages see near-term upside in Dr Reddy’s on Semaglutide, ex-US growth (Soban News)

Dr Reddy’s Laboratories reported a consolidated Q2FY26 net profit of ₹1,437.2 crore, up 14 per cent Y-o-Y from ₹1,255.3 crore, with sequential growth largely flat.​Dr Reddy’s Laboratories reported a consolidated Q2FY26 net profit of ₹1,437.2 crore, up 14 per cent Y-o-Y from ₹1,255.3 crore, with sequential growth largely flat. ​Latest News [ SOBAN NEWS: International and National ]

Related posts

Stocks to Watch today: HCLTech, Ambuja Cements, IRCTC, Paytm, Belrise Ind (Soban News)

News-Soban-Admin

Air India to add more flights to Toronto, Frankfurt, Paris amid high demand (Soban News)

News-Soban-Admin

OnePlus 15T unveiling on March 24 with 7500mAh battery: What to expect (Soban News)

News-Soban-Admin

Leave a Comment